Table 1.
Patients’ characteristics
| Variables | N | % |
|---|---|---|
| Age | ||
| Median | 62.5 | |
| Quartiles | 50.3-69 | |
| Gender | ||
| Female VS Male | 26:26 | 50: 50 |
| Clinical stage | ||
| III B VS IV | 3:49 | 5.8: 94.2 |
| Histological diagnosis | ||
| Adenocarcinoma VS Others | 51:1 | 98.1: 1.9 |
| Anti-EGFR therapy | ||
| Gefitinib | 34 | 65.4 |
| Erlotinib | 7 | 13.5 |
| Ectinib | 9 | 17.3 |
| Ositinib | 2 | 3.8 |
| Other treatments | ||
| Thoracic surgery | 2 | 4.3 |
| Radiotherapy | 2 | 4.3 |
| Chemotherapy | 39 | 82.9 |
| Radiofrequency ablation | 3 | 6.4 |
| Radioactive seed implantation | 1 | 2.1 |
| Concomitant diseases | ||
| Arterial hypertension | 14 | 43.7 |
| Diabetes mellitus | 9 | 28.1 |
| Heart disease | 3 | 9.4 |
| Chronic obstructive pulmonary disease | 3 | 9.4 |
| Cerebral infarction | 3 | 9.4 |
| Smoking | ||
| Past/current | 17 | 32.7 |
| Never | 35 | 67.3 |
| D-dimer content | ||
| Decrease VS Increase | 37:15 | 71.2: 28.8 |
| Platelet count | ||
| Decrease VS Increase | 33: 19 | 63.5: 36.5 |